bone tumor
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: (1) Primary bone tumors (benign, intermediate/borderline, or malignant) confirmed by histopathology. It is emphasized that analyzable multimodal imaging data must be available. (2) At least one type of standardized imaging examination data (e.g., X-ray, CT, or MRI) is available at baseline, with two or more types recommended. The imaging quality must meet the requirements for AI model analysis. (3) Written informed consent has been obtained from the patient or their legal guardian.
Exclusion criteria
Exclusion criteria: (1) Severe cardiac, hepatic, or renal dysfunction; severe mental or cognitive impairment that affects cooperation; pregnant or lactating women. (2) Previous antitumor treatments (e.g., chemotherapy, radiotherapy) that may interfere with the assessments of this study. (3) Contraindications to relevant imaging examinations (e.g., incompatible pacemakers or metal implants in the body); allergy to the contrast agents required for the study; concurrent participation in other interventional clinical trials that may interfere with the results of this study.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Receiver operating characteristic curve; | — |
Secondary
| Measure | Time frame |
|---|---|
| sensitivity;specificity;accuracy; | — |
Countries
China
Contacts
Shanghai Tenth People’s Hospital